Record Fourth Quarter Revenue
Financial Highlights:
Full year revenues of Euro 22.2 million, up 10% year-over-year
Record fourth quarter revenue of Euro 7.0 million, up 43% year-over-year
Robust 42% full year revenue attributed to Ablatherm-HIFU
Ablatherm-HIFU RPP treatments increased 36% year-over-year; 40% from fourth quarter 2006
Approximately 3,400 Ablatherm-HIFU treatments worldwide for year, yielding 15,000 cumulative treatments at 176 clinical sites
Successful launch of integrated Sonolith I-Sys for the disintegration of urinary stones
EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook Lyon, France, September 19, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in
EDAP TMS S.A. to Participate in International Urology Conferences LYON, France -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, today announces it is actively participating in the Societe Internationale d'Urologie (SIU)
EDAP TMS S.A. to Present at Roth Capital Conference in New York Lyon, France, August 24, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced management will present at the Roth Capital Partners New York
EDAP TMS S.A. to Present at the Roth Capital 2007 Orange County Conference Lyon, France, February 16, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and
EDAP TMS S.A. to Release 2006 Second Quarter Financial Results August 8, 2006 Lyon, France, August 3, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , will release its second quarter financial results for the period ending June 30, 2006 on Tuesday, August 8, 2006 after the market close.
EDAP TMS S.A. to Release 2006 Year End Financial Results Lyon, France, March 5, 2007 - EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide
EDAP TMS S.A. to Release 2007 First Quarter Results LYON, France , May 7 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution